ELEDON PHARMACEUTICALS INC (ELDN)

US28617K1016 - Common Stock

4.37  +0.1 (+2.34%)

After market: 4.23 -0.14 (-3.2%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/AN/AN/A
612.64%		N/A
88.71%		N/A
-21.37%
EBITDA
YoY % growth
-15.74M-23.44M
-48.92%		-45.15M
-92.62%		-37.95M
15.95%		-13.1M
65.48%		-14.05M
-7.25%		-14.17M
-0.85%		-16.18M
-14.18%		-36.87M
-127.87%		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-15.75M-23.46M
-48.95%		-45.26M
-92.92%		-38.12M
15.78%		-13.12M
65.58%		-14.06M
-7.16%		-14.18M
-0.85%		-16.19M
-14.17%		-36.87M
-127.73%		-39.78M
-7.89%		-43M
-8.09%		N/A
-52.62%		N/A
-27.20%		N/A
-29.34%		N/A
-60.60%		N/A
-17.65%		N/A
7.50%		N/A
0.54%		N/A
13.04%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/A-325.62
44.09%		-273.78
15.92%		N/A
85.58%		-28.08
28.86%		-22.86
18.59%		-13.21
42.22%		-2.32
82.43%		-2.76
-18.97%		-1.79
35.14%		N/A
34.47%		N/A
11.52%		N/A
19.41%		N/A
-19.51%		N/A
2.04%		N/A
67.71%		N/A
167.74%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.29
-1.12%		-0.31
10.00%		-0.32
69.69%		-0.32
1.19%		-0.29
0.87%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-20.191M
-95.31%		-21.42M
-97.07%		-22.695M
10.55%		-24.557M
-19.73%		-25.914M
-28.34%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.32
8.57%		-0.320.000.40%
Q2 2024
Q2Q % growth		 -1.06
-165.00%		-0.31-0.75-242.52%
Q1 2024
Q2Q % growth		 -0.34
54.67%		-0.370.038.80%
Q4 2023
Q2Q % growth		 -0.29
57.97%		-0.400.1127.47%
Q3 2023
Q2Q % growth		 -0.35
52.05%		-0.470.1225.49%
Q2 2023
Q2Q % growth		 -0.40
38.46%		-0.470.0714.53%
Q1 2023
Q2Q % growth		 -0.75
-8.70%		-0.61-0.14-22.75%
Q4 2022
Q2Q % growth		 -0.69
-16.95%		-0.720.033.53%
Q3 2022
Q2Q % growth		 -0.73
-10.61%		-0.69-0.04-5.25%
Q2 2022
Q2Q % growth		 -0.65
-30.00%		-0.720.079.48%
Q1 2022
Q2Q % growth		 -0.69
-21.05%		-0.690.000.15%
Q4 2021
Q2Q % growth		 -0.59
72.14%		-0.770.1822.88%
Q3 2021
Q2Q % growth		 -0.66
88.02%		-0.660.00-0.16%
Q2 2021
Q2Q % growth		 -0.50
76.85%		-0.580.0813.62%
Q1 2021
Q2Q % growth		 -0.57
83.33%		-0.33-0.24-74.63%
Q4 2020
Q2Q % growth		 -2.12
34.63%		-1.42-0.70-49.03%
Q3 2020
Q2Q % growth		 -5.51
-39.14%		-1.78-3.73-209.27%
Q2 2020
Q2Q % growth		 -2.16
65.71%		-3.030.8728.70%
Q1 2020
Q2Q % growth		 -3.42
63.46%		-2.94-0.48-16.42%
Q4 2019
Q2Q % growth		 -3.24
63.27%		-4.771.5332.13%
Q3 2019
Q2Q % growth		 -3.96
40.54%		-7.443.4846.74%
Q2 2019
Q2Q % growth		 -6.30
-2.94%		-7.801.5019.26%
Q1 2019
Q2Q % growth		 -9.36
-44.44%		-8.90-0.46-5.11%
Q4 2018
Q2Q % growth		 -8.82 -7.34-1.48-20.10%
Q3 2018
Q2Q % growth		 -6.66 -7.340.689.31%
Q2 2018
Q2Q % growth		 -6.12 -5.69-0.43-7.53%
Q1 2018
Q2Q % growth		 -6.48 -5.32-1.16-21.70%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 1.13% 26.16% 31.75%
RevenueN/A N/A N/A N/A